Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
KRM-1648
Description:
A benzoxazinorifamycin antibiotic investigated for activity against Mycobacterium tuberculosis and other mycobacterial infections.
Primary topic:
Mycobacterium research and diagnosis (43%)
Related topics:
Mycobacterium research and diagnosis (43%),
Tuberculosis Research and Epidemiology (29%),
Leprosy Research and Treatment (12%)
OpenAlex ID:
keywords/krm-1648
Contribution of rpoB Mutations to Development of Rifamycin Cross-Resistance in Mycobacterium tuberculosis
1998
·
D. L. Williams
, L. Spring
, et al.
·
Antimicrobial Agents and Chemotherapy
·
267
PDF
Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis
1998
·
B Yang
, H Koga
, et al.
·
Journal of Antimicrobial Chemotherapy
·
158
Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations
1996
·
S L Moghazeh
, X Pan
, et al.
·
Antimicrobial Agents and Chemotherapy
·
140
Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis
1996
·
B P Kelly
, S K Furney
, et al.
·
Antimicrobial Agents and Chemotherapy
·
118
PDF
In Vitro Anti- Helicobacter pylori Activities of New Rifamycin Derivatives, KRM-1648 and KRM-1657
1999
·
Junko K. Akada
, Mutsunori Shirai
, et al.
·
Antimicrobial Agents and Chemotherapy
·
63
In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis
1995
·
T Hirata
, H Saito
, et al.
·
Antimicrobial Agents and Chemotherapy
·
63
Comparative Antimicrobial Activities of the Newly Synthesized Quinolone WQ-3034, Levofloxacin, Sparfloxacin, and Ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium Complex
2000
·
Haruaki Tomioka
, Katsumasa Sato
, et al.
·
Antimicrobial Agents and Chemotherapy
·
61
Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice
1992
·
H Tomioka
, H Saito
, et al.
·
Antimicrobial Agents and Chemotherapy
·
58
HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes
1997
·
T Inaba
, N.E Fischer
, et al.
·
Toxicology Letters
·
52
In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli
1995
·
J Luna-Herrera
, M V Reddy
, et al.
·
Antimicrobial Agents and Chemotherapy
·
50
Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus
2001
·
T. A. Wichelhaus
, V Schäfer
, et al.
·
Journal of Antimicrobial Chemotherapy
·
49
Prospects for development of new antimycobacterial drugs
2000
·
Haruaki Tomioka
·
Journal of Infection and Chemotherapy
·
49
Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model
1994
·
S P Klemens
, M A Grossi
, et al.
·
Antimicrobial Agents and Chemotherapy
·
49
In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives
1994
·
K Fujii
, A Tsuji
, et al.
·
Antimicrobial Agents and Chemotherapy
·
38
Mechanism of action of antimycobacterial activity of the new benzoxazinorifamycin KRM-1648
1995
·
K Fujii
, H Saito
, et al.
·
Antimicrobial Agents and Chemotherapy
·
34
In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method
1993
·
H Tomioka
, H Saito
, et al.
·
Antimicrobial Agents and Chemotherapy
·
34
Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines
2000
·
Katsumasa Sato
, Haruaki Tomioka
, et al.
·
International Journal of Antimicrobial Agents
·
30
Pharmacokinetics of KRM-1648, a new benzoxazinorifamycin, in rats and dogs
1996
·
K Hosoe
, T Mae
, et al.
·
Antimicrobial Agents and Chemotherapy
·
30
PDF
Activity of KRM-1648 in combination with isoniazid against Mycobacterium tuberculosis in a murine model
1996
·
S P Klemens
, M H Cynamon
·
Antimicrobial Agents and Chemotherapy
·
29
Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages
1994
·
C B Inderlied
, L Barbara-Burnham
, et al.
·
Antimicrobial Agents and Chemotherapy
·
28
Antimicrobial activities of benzoxazinorifamycin (KRM-1648) and clarithromycin against Mycobacterium avium-intracellulare complex within murine peritoneal macrophages, human macrophage-like cells and human alveolar epithelial cells
1999
·
K. Sato
, H Tomioka
·
Journal of Antimicrobial Chemotherapy
·
25
Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits
1993
·
M Emori
, H Saito
, et al.
·
Antimicrobial Agents and Chemotherapy
·
24
Cross-resistance between rifampicin and KRM-1648 is associated with specific rpoB alleles in Mycobacterium tuberculosis.
2002
·
Y K Park
, B J Kim
, et al.
·
PubMed
·
23
In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis
1996
·
T Yamamoto
, R Amitani
, et al.
·
Antimicrobial Agents and Chemotherapy
·
23
PDF
Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection
1994
·
L E Bermudez
, P Kolonoski
, et al.
·
Antimicrobial Agents and Chemotherapy
·
23
Show more works
View as search
Works count:
117
Citation count:
1,941
Year
Topic
Type